Infection Complications in 476 Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide or Bortezomib Combinations

被引：0
|
作者：
Offidani, Massimo [1 ]
Corvatta, Laura [2 ]
Bringhen, Sara [3 ]
Gentili, Silvia [4 ]
Gay, Francesca [3 ]
Maracci, Laura [4 ]
Boccadoro, Mario [3 ]
Leoni, Pietro [4 ]
Palumbo, Antonio [3 ]
机构：
[1] Osped Riuniti Ancona, Haematol Clin, Ancona, Italy
[2] Osped Stelluti Fabriano, Internal Med, Fabriano, Italy
[3] AOU San Giovanni Battista Torino Osped Molinette, Div Hematol, Turin, Italy
[4] ADD Osped Riuniti Ancona, Clin Ematol, Ancona, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations
    Caravita, Tommaso
    Offidani, Massimo
    Siniscalchi, Agostina
    Gentili, Silvia
    Caraffa, Patrizia
    Perrotti, Alessio
    de Fabritiis, Paolo
    Leoni, Pietro
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (03) : 276 - 277
  • [2] INFECTION COMPLICATIONS IN AN UNSELECTED COHORT OF PATIENTS WITH MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE COMBINATIONS
    Caravita, T.
    Offidani, M.
    Siniscalchi, A.
    Gentili, S.
    Caraffa, P.
    Perrotti, A.
    De Fabritiis, D.
    Leoni, P.
    [J]. HAEMATOLOGICA, 2012, 97 : 612 - 612
  • [3] Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma
    Laubach, Jacob P.
    Schlossman, Robert L.
    Mitsiades, Constantine S.
    Anderson, Kenneth C.
    Richardson, Paul G.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 51 - 60
  • [4] Morphologic Classification Is an Important Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma Treated with Bortezomib or Lenalidomide
    Takakuwa, Teruhito
    Araki, Taku
    Nakamura, Koji
    Fukuyama, Tomoko
    Miura, Akiko
    Fujitani, Yotaro
    Hisanabe, Akari
    Kaieda, Anna
    Fukada, Erina
    Yamamura, Ryosuke
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (03): : 333 - 341
  • [5] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    [J]. BLOOD, 2010, 116 (05) : 679 - 686
  • [6] Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone
    Loncharich, Alexa J.
    Fiala, Mark A.
    Slade, Michael J.
    Vickroy, Angela
    Kavanaugh, Margaret
    Wilson, Carmen
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith
    Vij, Ravi
    Sanfilippo, Kristen M.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (11): : 825 - 828
  • [7] Venous Thromboembolism Risk in Patients with Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination with Lenalidomide and Dexamethasone
    Loncharich, Alexa J.
    Fiala, Mark A.
    Slade, Michael J.
    Vickroy, Angela
    Kavanaugh, Margaret
    Wilson, Kari
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    Sanfilippo, Kristen M.
    [J]. BLOOD, 2022, 140 : 8550 - 8551
  • [8] Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
    Liang, Dong
    Bai, Shenrui
    Feng, Demei
    Chen, Guanjun
    Liang, Yang
    Wang, Hua
    [J]. BMC CANCER, 2024, 24 (01)
  • [9] Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis
    Zonder, JA
    Barlogie, B
    Durie, BGM
    McCoy, J
    Crowley, J
    Hussein, MA
    [J]. BLOOD, 2006, 108 (01) : 403 - 403
  • [10] A Cost-Benefit Analysis of Bortezomib, Lenalidomide, and Bortezomib/Lenalidomide Combination Therapy for Newly Diagnosed Multiple Myeloma
    Fiala, Mark A.
    Wildes, Tanya M.
    Shah, Gunjan L.
    Ghobadi, Armin
    Schroeder, Mark A.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    [J]. BLOOD, 2017, 130
12345